A cost–utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer

David E. Cohn; Jason C. Barnett; Lari Wenzel; Bradley J. Monk; Robert A. Burger; J. Michael Straughn; Evan R. Myers; Laura J. Havrilesky

doi:10.1016/j.ygyno.2014.10.020

A cost–utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2014.10.020 ◽

2015 ◽

Vol 136 (2) ◽

pp. 293-299 ◽

Cited By ~ 18

Author(s):

David E. Cohn ◽

Jason C. Barnett ◽

Lari Wenzel ◽

Bradley J. Monk ◽

Robert A. Burger ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Economic Model ◽

Gynecologic Oncology ◽

Cost Utility ◽

Cost Utility Analysis ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Utility Analysis

Download Full-text

A cost-utility analysis of Gynecologic Oncology Group protocol 218: The importance of incorporating prospectively collected quality-of-life scores in health outcomes research

Gynecologic Oncology ◽

10.1016/j.ygyno.2014.03.025 ◽

2014 ◽

Vol 133 ◽

pp. 4 ◽

Cited By ~ 1

Author(s):

D.E. Cohn ◽

J.C. Barnett ◽

L. Wenzel ◽

B.J. Monk ◽

R.A. Burger ◽

...

Keyword(s):

Quality Of Life ◽

Health Outcomes ◽

Gynecologic Oncology ◽

Cost Utility ◽

Cost Utility Analysis ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Utility Analysis ◽

Health Outcomes Research

Download Full-text

Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.07.121 ◽

2017 ◽

Vol 147 (1) ◽

pp. 98-103 ◽

Cited By ~ 10

Author(s):

N.T. Phippen ◽

A.A. Secord ◽

S. Wolf ◽

G. Samsa ◽

B. Davidson ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Data Analysis ◽

Epithelial Ovarian Cancer ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Ancillary Data ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

Clinically meaningful quality-of-life changes in ovarian cancer: Results from gynecologic oncology group clinical trial 152

Clinical Therapeutics ◽

10.1016/s0149-2918(03)80262-x ◽

2003 ◽

Vol 25 ◽

pp. D26-D27

Author(s):

Lari Wenzel ◽

Bradley Monk ◽

Helen Huang ◽

David Cella ◽

Peter Rose

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Clinical Trial ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Life Changes ◽

Oncology Group

Download Full-text

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study

Journal of Pain and Symptom Management ◽

10.1016/j.jpainsymman.2009.09.022 ◽

2010 ◽

Vol 39 (5) ◽

pp. 839-846 ◽

Cited By ~ 25

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

Karen M. Gil ◽

Heidi E. Gibbons ◽

Bradley J. Monk ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Cancer Patients ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Life Domains ◽

Oncology Group ◽

Clinical Factors ◽

Oncology Group Study

Download Full-text

The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2011.11.032 ◽

2012 ◽

Vol 124 (3) ◽

pp. 379-382 ◽

Cited By ~ 32

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

Karen M. Gil ◽

Heidi E. Frasure ◽

Deborah K. Armstrong ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Overall Survival ◽

Adjuvant Chemotherapy ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Life Domains ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2018.05.017 ◽

2018 ◽

Vol 150 (1) ◽

pp. 119-126 ◽

Cited By ~ 3

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

David Cella ◽

MichaelA. Zevon ◽

Jason A. LaChance ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Care Needs ◽

Oncology Group Study ◽

Platinum Resistant

Download Full-text

Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials

Expert Review of Anticancer Therapy ◽

10.1586/era.10.57 ◽

2010 ◽

Vol 10 (7) ◽

pp. 987-991 ◽

Cited By ~ 1

Author(s):

Domenica Lorusso ◽

S Mainenti ◽

G Ferrandina ◽

G Scambia

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Cancer Trials

Download Full-text

Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials

Cancer ◽

10.1002/cncr.24520 ◽

2009 ◽

Vol 115 (20) ◽

pp. 4857-4864 ◽

Cited By ~ 41

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

Karen M. Gil ◽

Heidi E. Gibbons ◽

Bradley J. Monk ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Cancer Trials

Download Full-text

Association between quality of life and clinical outcome in women with advanced epithelial ovarian cancer receiving chemotherapy with concurrent and maintenance bevacizumab: Results from a prospective multicenter phase III NRG Oncology/Gynecologic Oncology Group (GOG) trial

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.04.019 ◽

2015 ◽

Vol 138 ◽

pp. 2

Author(s):

N.T. Phippen ◽

B.A. Davidson ◽

S. Wolf ◽

G. Samsa ◽

D. Cella ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Clinical Outcome ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Multicenter Phase ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

Quality of life (QOL) results of a randomized study of intravenous (IV) paclitaxel and cisplatin vs IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): A Gynecologic Oncology Group trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.5026 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5026-5026

Author(s):

L. B. Wenzel ◽

H. Huang ◽

D. Armstrong ◽

J. Walker ◽

D. Cella

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Gynecologic Oncology ◽

Randomized Study ◽

Stage Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Group Trial

Download Full-text